Albemarle Corporation

New York Stock Exchange
Back to all articles
Bullish +62

Albemarle Corporation $ALB Holdings Lifted by Amundi

AI-generated analysis

📈 Amundi increased its Albemarle holdings by 1.3% in Q1, adding 7,725 shares to a total position of 589,100 shares.

💰 Norges Bank and Phoenix Financial Ltd. established new stakes worth approximately $165.27 million and $130.42 million respectively in Q4.

📉 CEO J Kent Masters sold 16,393 shares for a total of $3.01 million on May 15th, reducing his ownership by 15.78%.

🚀 Albemarle reported Q1 revenue of $1.43 billion, beating estimates and showing a 32.7% year-over-year increase.

💵 The company posted quarterly EPS of $2.95, significantly surpassing the consensus estimate of $1.24.

📅 A quarterly dividend of $0.41 per share was declared with an ex-dividend date of September 11th.

🏦 Bank of America raised its price target to $225 and maintained a 'buy' rating on the stock.

📉 Robert W. Baird reduced its price target to $224 and set a 'neutral' rating for Albemarle.

🔋 The company's lithium segment supplies critical components for electric vehicle batteries and grid storage systems.

📊 Analyst consensus remains 'Moderate Buy' with a 15-to-10 ratio of buy to hold ratings.

Bullish Signals
  • Albemarle reported Q1 revenue of $1.43 billion, which beat the consensus estimate of $1.34 billion by $90 million.
  • The company achieved a significant earnings surprise with EPS of $2.95 compared to the expected $1.24.
  • Revenue grew 32.7% year-over-year, demonstrating strong top-line performance in the specialty chemicals sector.
  • Major institutional investors like Norges Bank and Phoenix Financial Ltd. established substantial new stakes worth over $165 million combined.
  • Bank of America raised its price target to $225 and reaffirmed a 'buy' rating on the stock.
  • The company declared a quarterly dividend of $0.41 per share, indicating a commitment to returning capital to shareholders.
Risk Factors
  • CEO J Kent Masters sold over $3 million worth of shares, reducing his personal ownership stake by 15.78%.
  • Robert W. Baird lowered its price target from $236 to $224 and downgraded the rating to 'neutral'.
  • Truist Financial reduced its price target from $260 to $245, although it maintained a 'buy' rating.
  • The dividend payout ratio is currently -47.51%, suggesting the dividend is being paid from cash reserves rather than earnings.
Full Analysis
Amundi increased its holdings in Albemarle Corporation (NYSE:ALB) by 1.3% in the first quarter, acquiring an additional 7,725 shares to own a total of 589,100 shares valued at approximately $105.76 million. Other institutional investors also adjusted their positions significantly during recent quarters, including Norges Bank and Phoenix Financial Ltd., which established new stakes worth roughly $165.27 million and $130.42 million respectively in the fourth quarter. CEO J Kent Masters sold 16,393 shares on May 15th at an average price of $183.72, totaling a transaction value of over $3 million. This sale reduced his direct ownership by 15.78%, leaving him with 87,519 shares valued at approximately $16.08 million. Following the earnings report issued on May 6th, the company reported quarterly revenue of $1.43 billion, beating consensus estimates, while posting EPS of $2.95 against an expectation of $1.24. Albemarle declared a quarterly dividend of $0.41 per share payable on October 1st for shareholders of record on September 11th, representing a yield of 1.4%. Analyst sentiment remains mixed with a consensus rating of 'Moderate Buy' and a target price of $199.22. Major banks like Bank of America and Wells Fargo have raised their price targets to $225 and $200 respectively, while Robert W. Baird lowered its target to $224 with a neutral rating. The specialty chemicals company is primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components for electric vehicle batteries, portable electronics, and grid storage systems. The firm's revenue grew 32.7% year-over-year to $1.43 billion, with analysts expecting full-year EPS of $12.79.